Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Donor Lymphocyte Infusions (DLI): Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
De Vos J, Baudoux E, Bay JO, Calmels B, Cras A, El Cheikh J, Guerout-Verite MA, Lacassagne MN, Lamure S, Letellier C, Menard AL, Daguindau E, Poiré X, Yakoub-Agha I, Guillaume T. De Vos J, et al. Among authors: el cheikh j. Bull Cancer. 2019 Jan;106(1S):S35-S39. doi: 10.1016/j.bulcan.2018.10.002. Epub 2018 Dec 20. Bull Cancer. 2019. PMID: 30580911 French.
Reduced-intensity conditioning with Fludarabin, oral Busulfan, and thymoglobulin allows long-term disease control and low transplant-related mortality in patients with hematological malignancies.
Blaise D, Farnault L, Faucher C, Marchetti N, Fürst S, El Cheikh J, Ladaique P, Vey N, Bouabdallah R, Stoppa AM, Lemarie C, Calmels B, Prebet T, Castagna L, Chabannon C, Mohty M, Esterni B. Blaise D, et al. Among authors: el cheikh j. Exp Hematol. 2010 Dec;38(12):1241-50. doi: 10.1016/j.exphem.2010.08.012. Epub 2010 Sep 17. Exp Hematol. 2010. PMID: 20850502
Comparable outcomes between unrelated and related donors after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation in patients with high-risk multiple myeloma.
El-Cheikh J, Crocchiolo R, Boher JM, Furst S, Stoppa AM, Ladaique P, Faucher C, Calmels B, Castagna L, Lemarie C, De Colella JM, Coso D, Bouabdallah R, Chabannon C, Blaise D. El-Cheikh J, et al. Eur J Haematol. 2012 Jun;88(6):497-503. doi: 10.1111/j.1600-0609.2012.01777.x. Epub 2012 Apr 4. Eur J Haematol. 2012. PMID: 22385049
Lenalidomide plus donor-lymphocytes infusion after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with high-risk multiple myeloma.
El-Cheikh J, Crocchiolo R, Furst S, Ladaique P, Castagna L, Faucher C, Granata A, Oudin C, Lemarie C, Calmels B, Stoppa AM, Schiano De Colella JM, Duran S, Chabannon C, Blaise D. El-Cheikh J, et al. Exp Hematol. 2012 Jul;40(7):521-7. doi: 10.1016/j.exphem.2012.02.009. Epub 2012 Mar 23. Exp Hematol. 2012. PMID: 22446605 Free article. Clinical Trial.
Two days of antithymocyte globulin are associated with a reduced incidence of acute and chronic graft-versus-host disease in reduced-intensity conditioning transplantation for hematologic diseases.
Crocchiolo R, Esterni B, Castagna L, Fürst S, El-Cheikh J, Devillier R, Granata A, Oudin C, Calmels B, Chabannon C, Bouabdallah R, Vey N, Blaise D. Crocchiolo R, et al. Among authors: el cheikh j. Cancer. 2013 Mar 1;119(5):986-92. doi: 10.1002/cncr.27858. Epub 2012 Oct 23. Cancer. 2013. PMID: 23096591 Free article.
182 results